2c:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/1bqb83_yclja0.js","/_next/static/immutable/chunks/1on664om2hmh1.js","/_next/static/immutable/chunks/30t4sjq-27eg7.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/32zk736rs0hqw.js","/_next/static/immutable/chunks/0lbgs964whs_0.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js","/_next/static/immutable/chunks/0hcnvyarhzl7i.js"],"default"] 2d:T677e,

Summary Table

Category	Details
Risk Factors	Primiparity, prior post-term pregnancy (strongest predictor), obesity (BMI >30), male fetus, fetal anencephaly, placental sulfatase deficiency, inaccurate dating (most common cause of apparent post-term diagnosis)
Etiology	Unknown in most cases; thought to involve failure of normal parturition signaling (deficient cortisol-prostaglandin cascade). Rare causes: fetal adrenal hypoplasia, anencephaly, placental sulfatase deficiency
Patient Presentation	Pregnant woman at or beyond 42 completed weeks (≥294 days from LMP) presenting for routine visit or with decreased fetal movement. May be asymptomatic.
Classic Physical Exam	Postmature (dysmature) newborn: peeling/parchment-like skin, long fingernails, meconium staining of skin/nails/cord, absent vernix caseosa, reduced subcutaneous fat, wrinkled skin, alert appearance
Key Diagnostic Results	Accurate gestational dating by first-trimester ultrasound is the single most important step. Antepartum surveillance: non-stress test (NST), amniotic fluid index (AFI) showing oligohydramnios (AFI ≤5 cm or deepest vertical pocket ≤2 cm), biophysical profile (BPP)
Management	Delivery is recommended between 41+0 and 42+0 weeks. Induction of labor with cervical ripening (prostaglandins if Bishop score <6, oxytocin if Bishop score ≥6). Cesarean delivery for failed induction or non-reassuring fetal status
Keywords	"42 weeks," "decreased fetal movement," "oligohydramnios," "meconium-stained fluid," "peeling skin and long nails," "placental insufficiency," "postmaturity syndrome," "uncertain dates"

1. Pathophysiology

Post-term pregnancy is defined as a pregnancy that has reached or exceeded 42 weeks and 0 days (≥294 days) from the first day of the last menstrual period. The term "late-term" refers to pregnancies between 41 weeks 0 days and 41 weeks 6 days, a distinction that matters because risk begins to climb during this window.

Normal labor initiation depends on a coordinated cascade: the fetal hypothalamic-pituitary-adrenal (HPA) axis produces cortisol, which stimulates placental conversion of progesterone to estrogen. Rising estrogen promotes prostaglandin synthesis and oxytocin receptor expression in the myometrium. When this signaling fails or is delayed, the pregnancy continues beyond term. In fetal anencephaly or adrenal hypoplasia, the absence of adequate fetal cortisol output directly disrupts this pathway. In placental sulfatase deficiency, estrogen precursors cannot be converted, and the progesterone-to-estrogen shift never occurs.

As the pregnancy extends beyond 42 weeks, the placenta undergoes progressive aging: calcification increases, villous surface area shrinks, and perfusion declines. This leads to uteroplacental insufficiency, which is the central mechanism linking post-term pregnancy to its complications. Reduced placental function causes decreased amniotic fluid production (oligohydramnios), impaired gas exchange (chronic fetal hypoxia), and nutrient restriction.

Oligohydramnios develops because fetal renal perfusion drops in response to redistribution of blood flow to vital organs (brain, heart, adrenals), reducing urine output. Less amniotic fluid means the umbilical cord is more vulnerable to compression, worsening intermittent hypoxia. This hypoxic environment triggers the fetal vagal reflex, causing meconium passage into the diminished amniotic fluid. Thick meconium in reduced fluid volume raises the risk of meconium aspiration syndrome (MAS) at delivery.

Fetal growth in post-term pregnancy follows two divergent paths. In about 20% of cases, the fetus continues to grow, resulting in fetal macrosomia (>4000 g), which increases the risk of shoulder dystocia, birth trauma, and cesarean delivery. In the remaining cases, placental insufficiency leads to dysmaturity syndrome (postmaturity syndrome): the fetus stops gaining weight, consumes subcutaneous fat stores, and is born with the classic wasted, wrinkled appearance with peeling skin and long nails.

The most feared complication is stillbirth. The risk of intrauterine fetal death doubles from 1 per 3,000 at 37 weeks to approximately 3 per 3,000 at 42 weeks and continues to rise with each additional week.

2. Classification and Clinical Manifestation

Gestational Age Classification

Term	Gestational Age	Clinical Significance
Early Term	37+0 to 38+6 weeks	Not fully mature; avoid elective delivery
Full Term	39+0 to 40+6 weeks	Optimal timing for delivery
Late Term	41+0 to 41+6 weeks	Risk begins to increase; antepartum surveillance indicated
Post-Term	≥42+0 weeks	Significantly elevated perinatal morbidity and mortality; delivery recommended

Clifford Classification

Stage	Skin Findings	Amniotic Fluid	Fetal Condition
Stage 1	Dry, cracked, peeling skin; absence of vernix caseosa and lanugo	Clear	Alert but thin; long fingernails
Stage 2	All Stage 1 findings plus meconium staining of skin, membranes, and cord	Green (meconium-stained)	Increased risk of aspiration
Stage 3	All Stage 2 findings plus deep yellow-green staining	Thick meconium	Severe compromise; high risk of stillbirth or neonatal death

Maternal vs. Fetal Complications

Maternal Complications	Fetal/Neonatal Complications
Increased cesarean section rate	Stillbirth / perinatal death
Labor dystocia (from macrosomia)	Meconium aspiration syndrome
Perineal trauma (3rd/4th degree tears)	Oligohydramnios and cord compression
Postpartum hemorrhage	Macrosomia and birth injury (brachial plexus, clavicle fracture)
Chorioamnionitis (prolonged labor)	Neonatal seizures from hypoxic-ischemic encephalopathy
Operative vaginal delivery complications	Hypoglycemia, polycythemia in the newborn

3. Diagnostic Workup

Test	Purpose	Key Findings	Role
First-trimester ultrasound (crown-rump length)	Establish accurate gestational age	Most accurate dating method (±5-7 days)	Best initial step to confirm or refute post-term status
Non-Stress Test (NST)	Assess fetal heart rate reactivity	Reactive = reassuring; non-reactive = further evaluation needed	Screening / surveillance tool
Amniotic Fluid Index (AFI)	Evaluate amniotic fluid volume	AFI ≤5 cm or single deepest pocket ≤2 cm = oligohydramnios	Key indicator of placental insufficiency
Biophysical Profile (BPP)	Comprehensive fetal well-being assessment	Score of 8-10 = reassuring; ≤6 = consider delivery	Combines NST + 4 ultrasound parameters
Modified BPP	Simplified surveillance	Combines NST + AFI only	Most commonly used in practice for twice-weekly surveillance
Contraction Stress Test (CST)	Evaluate fetal reserve under stress	Positive (late decelerations) = poor fetal reserve	Rarely used; reserved for equivocal results
Doppler velocimetry (umbilical artery)	Assess placental resistance	Absent or reversed end-diastolic flow = severe compromise	Not routine for post-term; used when IUGR is suspected

The single most important question in any vignette about post-term pregnancy is: "Are the dates accurate?" The most common reason a pregnancy appears post-term is inaccurate dating based on an unreliable last menstrual period. A first-trimester ultrasound using crown-rump length is the gold standard for dating, accurate to within 5 to 7 days. If a patient presents at "43 weeks by LMP" but had no early ultrasound, the true gestational age may be significantly different. On an exam, look for the stem to mention whether a dating ultrasound was performed. If it was not, the best initial step is often to obtain or review ultrasound dating before proceeding with intervention.

Once the gestational age is confirmed and the pregnancy is truly at or beyond 41 weeks, the next step is antepartum fetal surveillance. The most commonly used approach is the modified biophysical profile (modified BPP), which combines a non-stress test with amniotic fluid index measurement. This is performed twice weekly starting at 41 weeks.

The non-stress test evaluates the fetal heart rate pattern. A reactive NST (two or more accelerations of ≥15 beats per minute lasting ≥15 seconds within a 20-minute window) is reassuring. A non-reactive NST warrants further evaluation with a full BPP or contraction stress test.

The amniotic fluid index is the sum of the deepest vertical pockets in four uterine quadrants. An AFI of ≤5 cm (or a single deepest vertical pocket of ≤2 cm) indicates oligohydramnios, which in the post-term setting reflects declining placental function and reduced fetal renal perfusion. Oligohydramnios in a post-term pregnancy is an indication for delivery regardless of other findings.

The full biophysical profile scores five parameters, each worth 0 or 2 points (maximum score of 10): fetal breathing movements, gross body movements, fetal tone, amniotic fluid volume, and NST. A score of 8 to 10 (with normal fluid) is reassuring. A score of 6 is equivocal and requires repeat testing or delivery depending on gestational age. A score of 4 or below warrants delivery.

4. Management and Treatment

Clinical Scenario	Management	Details
Confirmed ≥41+0 weeks, favorable cervix (Bishop ≥6)	Induction of labor with oxytocin	Oxytocin IV infusion per institutional protocol (typically start at 1-2 mU/min, titrate every 15-30 min)
Confirmed ≥41+0 weeks, unfavorable cervix (Bishop <6)	Cervical ripening, then induction	Prostaglandin E2 (dinoprostone, 10 mg vaginal insert or 0.5 mg intracervical gel) or prostaglandin E1 (misoprostol, 25 mcg intravaginally every 3-6 hours); mechanical methods: Foley catheter balloon (30-80 mL)
Confirmed ≥42+0 weeks	Delivery is indicated	Induction of labor; if contraindications to vaginal delivery, proceed to cesarean
Non-reassuring fetal surveillance (non-reactive NST, BPP ≤6, oligohydramnios)	Delivery regardless of gestational age	Mode depends on clinical scenario; emergent cesarean if fetal distress
Meconium-stained amniotic fluid during labor	Continuous fetal monitoring; prepare for neonatal resuscitation	Amnioinfusion may be considered if variable decelerations are present; pediatric team at delivery
Patient declines induction at 41 weeks	Twice-weekly surveillance (modified BPP); counsel on risks	Document informed refusal; escalate to delivery if surveillance becomes abnormal

Step 1: Confirm gestational age. Review the earliest available ultrasound. If first-trimester dating was performed and confirms ≥41 weeks, proceed. If no early ultrasound exists, clinical judgment is required, but most guidelines recommend managing as if the dates are correct rather than waiting.

Step 2: Assess cervical readiness. Perform a digital cervical exam and calculate the Bishop score, which evaluates dilation, effacement, station, consistency, and position. A Bishop score of 6 or greater predicts successful induction and allows direct oxytocin administration. A score below 6 requires cervical ripening before oxytocin.

Step 3: Cervical ripening (if needed). The two main options are pharmacologic and mechanical.

For pharmacologic ripening, misoprostol (prostaglandin E1) at 25 mcg placed intravaginally every 3 to 6 hours is effective and inexpensive. Dinoprostone (prostaglandin E2) is available as a vaginal insert (10 mg, slow-release over 12 hours) or intracervical gel (0.5 mg every 6 hours, maximum 3 doses). Prostaglandins are absolutely contraindicated in patients with a prior cesarean scar or any history of uterine surgery due to the elevated risk of uterine rupture.

For mechanical ripening, a transcervical Foley catheter (inflated with 30 to 80 mL of saline) provides gentle dilation and can be used safely in patients with prior uterine scars when prostaglandins are contraindicated.

Step 4: Induction with oxytocin. Once the cervix is favorable, oxytocin is administered as a continuous IV infusion. Low-dose protocols begin at 1 to 2 mU/min with incremental increases every 15 to 30 minutes. The goal is achieving an adequate contraction pattern (3 to 5 contractions per 10 minutes) while monitoring for tachysystole.

Step 5: Intrapartum monitoring. Continuous electronic fetal monitoring is required during induction. Watch for late decelerations (a sign of uteroplacental insufficiency) and variable decelerations (suggesting cord compression, particularly with oligohydramnios). If meconium-stained fluid is noted at amniotomy, alert the neonatal team and maintain continuous monitoring.

Step 6: Cesarean delivery. Indicated for failed induction (inability to achieve active labor despite adequate oxytocin and time) or non-reassuring fetal heart rate tracings that do not respond to intrauterine resuscitation (maternal repositioning, IV fluid bolus, discontinuation of oxytocin, or amnioinfusion).

Key Contraindications to Know

Contraindication	Implication
Prior classical (vertical) cesarean incision	Contraindication to labor induction; proceed to repeat cesarean
Prior low-transverse cesarean (one scar)	May attempt trial of labor (TOLAC) but prostaglandins are contraindicated; use mechanical ripening + oxytocin
Active genital herpes outbreak	Contraindication to vaginal delivery; cesarean indicated
Placenta previa	Contraindication to labor; cesarean delivery

5. Differential Diagnosis and Distractors

Differential	Why It Is Similar	Key Discriminator
Intrauterine Growth Restriction (IUGR)	Both present with oligohydramnios and a small-for-dates fetus on exam	IUGR shows abnormal Doppler velocimetry (absent/reversed end-diastolic flow in the umbilical artery) and is diagnosed by estimated fetal weight <10th percentile regardless of gestational age. Post-term is defined by gestational age ≥42 weeks, and the fetus may actually be macrosomic.
Oligohydramnios from other causes (renal agenesis, PPROM)	Both present with low amniotic fluid on ultrasound	In post-term pregnancy, oligohydramnios develops gradually due to placental insufficiency; there is no rupture of membranes, and fetal kidneys are present on ultrasound. PPROM presents with fluid leaking, positive pooling/ferning/nitrazine. Renal agenesis shows absent kidneys bilaterally on ultrasound.
Inaccurate dating (not truly post-term)	The biggest "distractor" on exams; a late-term patient with uncertain LMP appears post-term	First-trimester ultrasound dating resolves this. Vignettes emphasizing "unsure LMP," "irregular cycles," or "no prenatal care" are hinting that the dates may be wrong and that ultrasound confirmation is the best first step.
Gestational diabetes with macrosomia	Both can present with a large-for-gestational-age fetus and risk of shoulder dystocia	Gestational diabetes is identified by glucose screening (1-hour GCT >140 mg/dL, confirmed by 3-hour GTT). Macrosomia in GDM occurs at any gestational age and is associated with polyhydramnios (excess fluid), whereas post-term classically shows oligohydramnios.
Preeclampsia with IUGR	Can present with oligohydramnios and abnormal fetal surveillance near term	Preeclampsia is identified by hypertension (≥140/90 mmHg) and proteinuria (≥300 mg/24 hours) or other end-organ damage. Post-term pregnancy does not feature hypertension or proteinuria.
Meconium aspiration syndrome (MAS)	Both are associated with meconium-stained amniotic fluid	MAS is a neonatal diagnosis (respiratory distress after delivery with meconium below the cords), not an antenatal one. Post-term pregnancy is the risk factor for MAS, not the same condition. A vignette describing a newborn with respiratory distress after a post-term delivery is testing MAS, not post-term management.

6. Traps and High-Yield Pearls

The single most common trap in questions about post-term pregnancy involves dating. A vignette will present a woman at "43 weeks by her last menstrual period" who had no early ultrasound, irregular cycles, or uncertain dates. The temptation is to jump straight to induction of labor, but the best initial step is to confirm gestational age with the most reliable data available. If no first-trimester ultrasound exists, the question is testing whether you understand that the diagnosis of post-term pregnancy itself may be wrong before you intervene.

The second common trap is the oligohydramnios trigger. When a vignette describes a post-term patient with an AFI of 4 cm or a deepest pocket of 1.5 cm, the answer is delivery, not continued surveillance. Students who choose "repeat BPP in 24 hours" lose the point because oligohydramnios in a post-term pregnancy is an independent indication for delivery.

A third pitfall involves prostaglandin use in patients with a prior cesarean. If the vignette mentions a previous low-transverse cesarean scar and an unfavorable cervix at 41 weeks, the answer is mechanical ripening with a Foley catheter, not misoprostol. Selecting misoprostol in this scenario is a high-yield wrong answer designed to catch students who do not recognize the contraindication.

Finally, remember the fetal versus neonatal distinction. A question describing a post-term fetus with non-reassuring heart tracings is testing antepartum management (delivery). A question describing a newborn with respiratory distress, meconium below the cords, and a chest X-ray showing patchy infiltrates is testing meconium aspiration syndrome, a neonatal condition. The management shifts from obstetric intervention to neonatal resuscitation and respiratory support. Recognizing which phase of care the vignette is testing is the core competency.

The overarching skill being assessed in post-term pregnancy questions is the ability to sequence clinical decisions correctly: confirm dates first, then initiate surveillance, then decide on delivery timing and method based on cervical status and fetal well-being. Every wrong answer on these questions comes from skipping a step or acting on incomplete information.

1d:["$","$L2c",null,{"article":{"id":"011c471b-35ba-4905-a151-dc6af090fb94","title":"Kehamilan Post-Term","content":"$2d","category":"Reproduksi","created_at":"2026-09-05T11:19:07.0085+00:00","status":"published","subcategory":null},"questionCount":0,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]